The Cancer Vaccine Center is Developing
Safe, Effective Vaccines for Patients With Cancer

  • Image
  • Image
  • Image

Welcome to the Cancer Vaccine Center (CVC). We are developing safe and effective vaccines for patients with cancer. The CVC maintains an integrated program of scientific discovery, preclinical vaccine development and clinical investigation. As part of Dana-Farber Cancer Institute, the CVC is affiliated with Harvard Medical School and Dana-Farber/Harvard Cancer Center.


CVC Feature

Investigators at Dana-Farber Cancer Institute, Harvard Medical School, and the Massachusetts Institute of Technology used an array of techniques to discover that T cells function as mechanosensors.

READ MORE | VIEW PDF

Leadership & Innovation

The CVC in conjunction with Dana-Farber Cancer Institute combines comprehensive facilities and capabilities to streamline the development of cancer vaccines.

Latest CVC News

11.02.09 Study Reveals "Missing Link" in Immune Response to Disease. Investigators Sun Taek Kim, Ellis L. Reinherz et al. describe how T cell receptors can ...

READ MORE | VIEW MORE NEWS